Literature DB >> 11892038

Mechanisms of allergic rhinitis.

J N Baraniuk1.   

Abstract

The pathogenesis of allergic rhinitis can be better appreciated by understanding the numerous protective mechanisms available for mucosal defense. The system of TH2 lymphocytes, IgE production, mast cell degranulation, eosinophil infiltration, and resident cell responses are central to our understanding and treatment of allergic rhinitis. Histamine remains preeminent in causing the cardinal symptoms of the immediate allergic reaction: itching, watery discharge, and nasal swelling. Recruitment and activation mechanisms responsible for the late-phase allergic response are also reviewed.

Entities:  

Mesh:

Year:  2001        PMID: 11892038     DOI: 10.1007/s11882-001-0007-5

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  65 in total

Review 1.  Eosinophils and airway nerves in asthma.

Authors:  R W Costello; D B Jacoby; G J Gleich; A D Fryer
Journal:  Histol Histopathol       Date:  2000-07       Impact factor: 2.303

2.  Characterization and autoradiographic localization of histamine H1 receptors in human nasal turbinates.

Authors:  M Okayama; J N Baraniuk; J N Hausfeld; M Merida; M A Kaliner
Journal:  J Allergy Clin Immunol       Date:  1992-06       Impact factor: 10.793

3.  Neuropeptidergic innervation of human nasal mucosa in various pathological conditions.

Authors:  S Y Fang; C L Shen
Journal:  Proc Natl Sci Counc Repub China B       Date:  1997-01

Review 4.  Neurogenic inflammation in the respiratory tract: actions of sensory nerve mediators on blood vessels and epithelium of the airway mucosa.

Authors:  D M McDonald
Journal:  Am Rev Respir Dis       Date:  1987-12

5.  Effects of hCGRP 8-37 and the NK1-receptor antagonist SR 140.333 on capsaicin-evoked vasodilation in the pig nasal mucosa in vivo.

Authors:  J Rinder; J M Lundberg
Journal:  Acta Physiol Scand       Date:  1996-02

6.  Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients.

Authors:  B L Mosimann; M V White; R J Hohman; M S Goldrich; H C Kaulbach; M A Kaliner
Journal:  J Allergy Clin Immunol       Date:  1993-07       Impact factor: 10.793

7.  TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis.

Authors:  P Bradding; R Mediwake; I H Feather; J Madden; M K Church; S T Holgate; P H Howarth
Journal:  Clin Exp Allergy       Date:  1995-05       Impact factor: 5.018

8.  M1 and M3 muscarinic antagonists inhibit human nasal glandular secretion in vitro.

Authors:  J Mullol; J N Baraniuk; C Logun; M Mérida; J Hausfeld; J H Shelhamer; M A Kaliner
Journal:  J Appl Physiol (1985)       Date:  1992-11

9.  Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis.

Authors:  U Martin; K Bryden; M Devoy; P Howarth
Journal:  J Allergy Clin Immunol       Date:  1996-03       Impact factor: 10.793

10.  Proteinase content of mast cells of nasal mucosa; effects of natural allergen exposure and of local corticosteroid treatment.

Authors:  S Juliusson; F Aldenborg; L Enerbäck
Journal:  Allergy       Date:  1995-01       Impact factor: 13.146

View more
  6 in total

Review 1.  Human nasal allergen provocation for determination of true allergic rhinitis: methods for clinicians.

Authors:  Ludmila I Litvyakova; James N Baraniuk
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

2.  Expression of HSP70 in peripheral lymphocytes of the patients with allergic rhinitis.

Authors:  Lisi Liu; Chengfeng Xiao; Ming Zhang; Lei Cheng; Efen Wang; Tangchun Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

3.  Systemic administration of olygodeoxynucleotides with CpG motifs at priming phase reduces local Th2 response and late allergic rhinitis in BALB/c mice.

Authors:  Toshiharu Hayashi; Keiko Hasegawa; Yuji Sasaki
Journal:  Inflammation       Date:  2007-09-12       Impact factor: 4.092

4.  Essential Contribution of CD4+ T Cells to Antigen-Induced Nasal Hyperresponsiveness in Experimental Allergic Rhinitis.

Authors:  Tomoe Nishimura; Osamu Kaminuma; Mayumi Saeki; Noriko Kitamura; Kunie Matsuoka; Hiromichi Yonekawa; Akio Mori; Takachika Hiroi
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

5.  Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.

Authors:  Natt Tasaniyananda; Urai Chaisri; Anchalee Tungtrongchitr; Wanpen Chaicumpa; Nitat Sookrung
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

6.  Assessment of tumor growth factor-β1 neutralizing antibody in the treatment of allergic rhinitis and asthma.

Authors:  Yan Wei; Zhili Zhang; Feng Wang; Shuihong Zhou
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.